SKI Market

Indian Indices

Nifty

22,147.00 151.15
(0.69%)

Sensex

73,088.33 599.34
( 0.83%)

Bank Nifty

47,574.15 504.70
( 1.07%)

Nifty IT

33,368.30 -130.35
( -0.39%)

Global Indices

Nasdaq

15,282.01 -319.49
(-2.05%)

Dow Jones

37,986.40 211.02
(0.56%)

Hang Seng

16,224.14 -161.73
(-0.99%)

Nikkei 225

37,068.35 -1,011.35
(-2.66%)

Forex

USD-INR

83.55 -0.08
(-0.10%)

EUR-INR

89.09 0.07
(0.08%)

GBP-INR

104.07 -0.04
(-0.04%)

JPY-INR

0.54 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Syngene International Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

539268

INE398R01022

95.3873612

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SYNGENE

60.45

28675.73

EPS(TTM)

Face Value()

Div & Yield %

11.8

0.17

Particulars(INCOME)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)	Mar 2018 ( Cr)
Sales Turnover	3193.50	2601.40	2179.40	2011.90	1825.60	1423.10
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	3193.50	2601.40	2179.40	2011.90	1825.60	1423.10
Other Income	70.90	107.60	99.60	152.90	75.10	61.80
Stock Adjustments	42.00	21.60	25.20	-0.80	-26.00	13.50
Total Income	3306.40	2730.60	2304.20	2164.00	1874.70	1498.40
EXPENDITURE :
Raw Materials	902.20	770.60	551.70	518.60	505.30	395.20
Power & Fuel Cost	69.20	64.40	57.40	45.80	41.30	34.70
Employee Cost	812.20	697.80	641.50	572.20	465.40	376.90
Other Manufacturing Expenses	208.30	160.80	140.60	114.80	98.10	81.60
Selling & Administrative Expenses	226.70	157.90	123.10	132.80	131.70	119.30
Miscellaneous Expenses	82.60	63.60	20.30	10.20	22.20	-35.50
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	2301.20	1915.10	1534.60	1394.40	1264.00	972.20
Operating Profit	1005.20	815.50	769.60	769.60	610.70	526.20
Interest	45.20	24.10	27.70	34.60	32.30	22.70
Gross Profit	960.00	791.40	741.90	735.00	578.40	503.50
Depreciation	359.10	309.70	274.50	219.30	164.20	131.40
Profit Before Tax	600.90	481.70	467.40	515.70	414.20	372.10
Tax	115.60	87.60	46.80	51.20	86.40	79.30
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	12.30	0.30	16.90	53.00	-2.90	-12.30
Reported Net Profit	473.00	393.80	403.70	411.50	330.70	305.10
Extraordinary Items	2.50	-21.84	25.16	53.65	3.48	16.05
Adjusted Net Profit	470.50	415.64	378.54	357.85	327.22	289.05
Adjustment below Net Profit	-70.20	0.00	-0.10	-201.70	-0.40	0.40
P & L Balance brought forward	2573.30	2179.50	1775.90	1590.20	1284.00	1002.60
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	24.10	24.10	24.10
P & L Balance carried down	2976.10	2573.30	2179.50	1775.90	1590.20	1284.00
Dividend	0.00	0.00	0.00	0.00	0.00	20.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	12.50	10.00	0.00	0.00	5.00	10.00
Dividend Per Share(Rs)	1.25	1.00	0.00	0.00	0.50	1.00
Earnings Per Share-Unit Curr	11.78	9.83	10.09	10.29	16.54	15.26
Earnings Per Share(Adj)-Unit Curr	11.78	9.83	10.09	10.29	8.27	7.63
Book Value-Unit Curr	90.16	82.14	70.46	54.35	98.36	86.01
Book Value(Adj)-Unit Curr	90.16	82.14	70.46	54.35	49.18	43.01

22,147.00 151.15 (0.69%)

73,088.33 599.34 ( 0.83%)

47,574.15 504.70 ( 1.07%)

33,368.30 -130.35 ( -0.39%)

15,282.01 -319.49 (-2.05%)

37,986.40 211.02 (0.56%)

16,224.14 -161.73 (-0.99%)

37,068.35 -1,011.35 (-2.66%)

83.55 -0.08 (-0.10%)

89.09 0.07 (0.08%)

104.07 -0.04 (-0.04%)

0.54 0.00 (-0.04%)